Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human Huntingtin Antibodies:
anti-Mouse (Murine) Huntingtin Antibodies:
anti-Rat (Rattus) Huntingtin Antibodies:
Go to our pre-filtered search.
Human Polyclonal Huntingtin Primary Antibody for ELISA, ICC - ABIN4320700
Hall, Georgel: CHD proteins: a diverse family with strong ties. in Biochemistry and cell biology = Biochimie et biologie cellulaire 2007
Show all 3 Pubmed References
Human Monoclonal Huntingtin Primary Antibody for IHC (fro), IP - ABIN2474102
Moleman, Versluis, Bruinvels: Is morphine-induced catalepsy related to activation of dopaminergic neurones? in Psychopharmacology 1979
Show all 4 Pubmed References
Human Monoclonal Huntingtin Primary Antibody for IHC (fro), IP - ABIN2474103
Tseng, Hsu: A kinetic analysis of the repair of radiation-induced DNA double-strand breaks. in Radiation research 1990
Show all 4 Pubmed References
Human Monoclonal Huntingtin Primary Antibody for ELISA, WB - ABIN516379
Thompson, Aiken, Kaltenbach, Agrawal, Illes, Khoshnan, Martinez-Vincente, Arrasate, ORourke, Khashwji, Lukacsovich, Zhu, Lau, Massey, Hayden, Zeitlin, Finkbeiner, Green, LaFerla, Bates, Huang et al.: IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. ... in The Journal of cell biology 2009
These investigations demonstrate a specific 'rate-limiting' role for huntingtin in formation of the telencephalon and the pre-placodal region, and differing levels of requirement for huntingtin function in specific nerve cell types.
the effects of Htt deficiency in early zebrafish development.
In vivo, huntingtin deficient zebrafish had a severe phenotype and reduced expression of LXR (show NR1H3 Antibodies) reg'd genes. An LXR (show NR1H3 Antibodies) agonist partially rescued the phenotype and expression of LXR (show NR1H3 Antibodies) target genes in huntingtin deficient zebrafish during early development.
Jp modifies the neuronal degeneration in a Drosophila model of Huntington's disease, and it has uncoveedr an unsuspected functional relationship with the Notch (show NOTCH1 Antibodies) pathway.
Data strongly suggest that mutant Htt expression exclusively in all the CNS and PNS neurons leads to fluctuation of body weight, carbohydrate and protein stores, global lipid levels along with the intracellular lipid deposits through its effect on the integrated process of metabolic homeostasis. These results also support the idea that lipid metabolism remains centrally affected in HD leading to altered body weight.
These results therefore identify native Htt as a regulator of synaptic capture and neuropeptide storage.
Mutant HTT causes severe mislocalization and aggregation of nucleoporins and defective nucleocytoplasmic transport.
Early-onset sleep defects in mutated HTT Drosophila models of Huntington's disease reflect alterations of PKA/CREB signaling.
Htt aggregates cause non-cell-autonomous pathology, including loss of vulnerable neurons that can be prevented by inhibiting endocytosis in these neurons.
Glia regulate steady-state numbers of Htt aggregates expressed in neurons through a clearance mechanism that requires the glial scavenger receptor Draper and downstream phagocytic machinery.
findings support a role for HTT on dynamin 1 (show DNM1 Antibodies) function and ER homoeostasis. Proteolysis-induced alteration of this function may be relevant to disease.
Htt modulated histone H3K9 methylation levels at the heterochromatin-euchromatin boundary.
In Drosophila, Huntingtin genetically interacts with autophagy pathway components.
Study showed that SV2C (show SV2C Antibodies) is highly expressed in the basal ganglia and hippocampus of mice and that there is a specific and progressive decrease in SV2C (show SV2C Antibodies) mRNA and protein expression in both Huntington's disease (HD) mice and a cell model. These findings suggest that the synaptic dysfunction in HD results from the mutant Htt-mediated inhibition of SV2C (show SV2C Antibodies) transcriptional expression.
Inverse relationship has been found between the length of CAG HTT repeats and age at clinical onset of Huntington's Disease in Indian population.
Polyglutamine expansion appears to induce a 'change of function', possibly a 'gain of function', in the huntingtin protein, which leads to various molecular and cellular cascades of pathogenesis, including oxidative stress, mitochondrial dysfunction, glutamatergic dysfunction and neuroinflammation. [Review]
The number of repeats in HTT, had a non-linear effect on a measure of general intelligence with an inverted U shape pattern. Increasing repeat length was associated with higher GAI scores up until roughly 40-41 repeats. After this peak, increasing repeat length was associated with declining GAI scores.
Results show that not only prolonged fasting but also scheduled feeding without forcibly reducing calorie intake alters nutrient-sensing pathways and activates autophagy in mouse brain. This intervention furthermore reduces the amounts of mutant HTT protein, and may thus contribute to its clearance.
The single overexpression of DNAJB1 (show DNAJB1 Antibodies) in HEK293T cells is sufficient to profoundly reduce HttExon1Q97 aggregation and represents a target of future therapeutic avenues for HD.
The two kinases HIPK3 (show HIPK3 Antibodies) and MAPK11 (show MAPK11 Antibodies) effect on Huntingtin (HTT)levels are mutant HTT protein (mHTT)-dependent, providing a feedback mechanism in which mHTT enhances its own level thus contributing to mHTT accumulation and disease progression.
Lipid-based micellar nanoparticles promote aggregation of huntingtin exon-1 peptides. This study characterizes the interaction of two such peptides, htt(NT)Q7 and htt(NT)Q10 (show EIF2C2 Antibodies) comprising the N-terminal amphiphilic domain of huntingtin followed by 7 and 10 glutamine (show GFPT1 Antibodies) repeats, respectively, with 8 nm lipid micelles. Monomer-dimer equilibrium exists on the surface of the micelles.
Study shows that lifetime depression risk was higher with both relatively short and relatively large Huntigtin CAG repeat (show CELF3 Antibodies) sizes in the normal range.
huntingtin T3 phosphorylation is greatly reduced in samples from Huntington's disease models and in Huntington's disease patients, and T3 phosphorylation alters Huntingtin exon 1 protein conformation and aggregation properties
This study conclude that expanded polyglutamine repeats of htt protein influence Huntington's Disease pathogenesis in a sex-dependent manner
expression of mutant HTT in Sim1 (show SIM1 Antibodies) cells may play a role for the development of metabolic dysfunction and depressive-like behavior in male BACHD mice.
full-length endogenous Htt, which was immunoprecipitated from HD knock-in mouse and human post-mortem brain, is suitable for detection of PTMs (show PTMS Antibodies) by mass spectrometry
Knockdown of DNMT3A (show DNMT3A Antibodies) or DNMT1 (show DNMT1 Antibodies) protected neurons against mutant Htt-induced toxicity, together demonstrating a requirement for DNMTs in mutant Htt-triggered neuronal death and suggesting a neurodegenerative mechanism based on DNA methylation (show HELLS Antibodies)-mediated transcriptional repression.
Soluble mutant Httex1 stimulated the largest changes in the Neuro2a cells tanscriptome. Inactivated CREB (show CREB1 Antibodies) signalling is the most profound impact arising from soluble Httex1.
This study demonstrates that loss of Htt function during neural development leads to HD-like neurological abnormalities in mice.
treating BACHD cortical neurons with ApiCCT1 prevented BACHD striatal neuronal atrophy by enhancing release of BDNF (show BDNF Antibodies) that subsequently acts through tyrosine receptor kinase B (TrkB (show NTRK2 Antibodies)) receptor on striatal neurons. Our findings are evidence that TRiC (show MARVELD2 Antibodies) reagent-mediated reductions in mHTT enhanced BDNF (show BDNF Antibodies) delivery to restore the trophic status of BACHD striatal neurons.
identify 4 huntingtin-targeting miRNAs viz. miR (show MLXIP Antibodies)-125b, miR (show MLXIP Antibodies)-146a, miR (show MLXIP Antibodies)-150 and miR (show MLXIP Antibodies)-214 as candidate miRNAs responsible for observed inhibitory effect of HSF1 (show HSF1 Antibodies) on huntingtin expression.
cells expressing mutant huntingtin have a dysregulated transcriptional response to epidermal growth factor (show EGF Antibodies) stimulation
Mutant htt is implicated in Huntington's disease-related alterations of neurotransmission.
Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range in the number of trinucleotide repeats has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression.
, Huntington's disease protein
, huntingtin (Huntington disease)
, solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
, Huntington disease
, huntington disease protein
, HD protein homolog
, Huntington disease gene homolog
, huntington disease protein homolog